Home Latest Filings Latest Buys Latest Sells Institutions Derivatives Hot Buys Data Screener Email Alerts Insider Charts
CBYL - As of  04/30/25, 10:25:54 AM:   37 Insider Transactions.

Sector:    Industry:
Prev Close:$0.67  Avg Vol(3m): 1,641,320  P/E: 0.00  EPS: -1.03

Email this page to a friend.    Insider Transactions for CBYL

Buy/Sell* Filed Date Subject Symbol Acquirer Pct Owned Details
B 2020-04-10 14:01:18.0 KalVista Pharmaceuticals KALV FMR LLC 10.034% view
B 2020-03-23 16:28:32.0 KalVista Pharmaceuticals KALV Ikarian Capital 5.3% view
S 2020-02-14 16:07:48.0 KalVista Pharmaceuticals KALV Venrock Healthcare Capital Partners II 5.5% view
S 2020-02-13 16:30:18.0 KalVista Pharmaceuticals KALV Vivo Ventures VI 5.7% view
S 2020-02-13 12:45:19.0 KalVista Pharmaceuticals KALV Flynn James E 0.0% view
B 2020-02-04 15:51:28.0 KalVista Pharmaceuticals KALV EVENTIDE ASSET MANAGEMENT 9.4% view
B 2019-04-18 18:35:52.0 KalVista Pharmaceuticals KALV Flynn James E 7.06% view
S 2019-04-15 16:35:35.0 KalVista Pharmaceuticals KALV RA CAPITAL MANAGEMENT 5.6% view
S 2019-04-03 15:27:02.0 KalVista Pharmaceuticals KALV SVLSF IV 10.3% view
S 2019-03-20 16:43:02.0 KalVista Pharmaceuticals KALV SVLSF IV 11.5% view
S 2018-09-12 16:32:32.0 KalVista Pharmaceuticals KALV Vivo Ventures VI 6.0% view
B 2018-09-10 16:30:55.0 KalVista Pharmaceuticals KALV Venrock Healthcare Capital Partners II 12.3% view
B 2018-08-09 16:33:24.0 KalVista Pharmaceuticals KALV Venrock Healthcare Capital Partners II 9.5% view
B 2018-02-12 17:20:50.0 KalVista Pharmaceuticals KALV EVENTIDE ASSET MANAGEMENT 6.6% view
B 2017-11-13 16:31:49.0 KalVista Pharmaceuticals KALV RA CAPITAL MANAGEMENT 14.8% view
B 2017-10-20 16:42:02.0 KalVista Pharmaceuticals KALV Longwood Fund II 8.7% view
B 2017-10-16 10:59:02.0 KalVista Pharmaceuticals KALV Merck & Co 9.9% view
S 2017-10-13 16:56:03.0 KalVista Pharmaceuticals KALV Novo Holdings A 0.0% view
S 2017-09-22 17:21:56.0 KalVista Pharmaceuticals KALV Novo Holdings A 28.06% view
B 2017-03-02 09:26:02.0 KalVista Pharmaceuticals CBYL SVLSF IV 26.6% view
B 2017-02-14 16:26:39.0 KalVista Pharmaceuticals CBYL RA CAPITAL MANAGEMENT 6.0% view
B 2017-02-13 16:54:54.0 KalVista Pharmaceuticals CBYL Vivo Ventures VI 16.0% view
S 2017-02-07 14:51:49.0 KalVista Pharmaceuticals CBYL FRANKLIN RESOURCES INC 0.0% view
B 2017-02-07 06:13:02.0 KalVista Pharmaceuticals CBYL SVLSF IV 26.6% view
B 2016-11-30 16:24:02.0 KalVista Pharmaceuticals CBYL Novo A 29.2% view
S 2016-09-12 13:37:37.0 Carbylan Therapeutics CBYL PRICE T ROWE ASSOCIATES INC 1.7% view
S 2016-05-10 08:40:11.0 Carbylan Therapeutics CBYL FMR LLC 0.002% view
S 2016-04-11 09:57:07.0 Carbylan Therapeutics CBYL FMR LLC 7.413% view
S 2016-02-12 12:31:56.0 Carbylan Therapeutics CBYL PRICE T ROWE ASSOCIATES INC 10.2% view
B 2016-02-12 09:01:23.0 Carbylan Therapeutics CBYL FMR LLC 12.784% view
B 2016-02-04 13:40:59.0 Carbylan Therapeutics CBYL FRANKLIN RESOURCES INC 5.5% view
B 2015-05-11 14:17:50.0 Carbylan Therapeutics CBYL PRICE T ROWE ASSOCIATES INC 10.7% view
B 2015-05-11 09:16:54.0 Carbylan Therapeutics CBYL FMR LLC 12.622% view
B 2015-04-24 16:17:31.0 Carbylan Therapeutics CBYL ACP IV 16.6% view
B 2015-04-23 21:12:08.0 Carbylan Therapeutics CBYL Vivo Ventures VI 16.0% view
B 2015-04-21 06:16:00.0 Carbylan Therapeutics CBYL InterWest Partners IX 17.6% view
B 2015-04-14 16:31:38.0 Carbylan Therapeutics n/a Broadfin Capital 5.2% view
* Institutions do not report transaction buy/sell types directly. To help members better understand the transactions, this column is filled by InsiderCow's best-effort interpretations.